StockData
Integrated BioPharma Inc logo

Integrated BioPharma Inc (INBP) stock

INBPOTCPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$0.18+0.00 (0.00%)

Close on Oct 19, 2026Market cap $5.59MP/E –Yield –

Integrated BioPharma EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Integrated BioPharma's EV/EBITDA was 2.3× on Apr 30, 2026, against 3.6× a year earlier. Over the last 5 years it ranged from 1.9× to 22.6×, with a median of 5.8×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Apr 30, 20262.3×−0.9
2025Dec 31, 20253.1×−3.8
2024Dec 31, 20246.9×−6.2
2023Dec 29, 202313.1×+9.4
2022Dec 30, 20223.7×−2.3
2021Dec 31, 20216.0×+0.5
2020Dec 31, 20205.5×+2.2
2019Dec 31, 20193.3×−0.4
2018Dec 31, 20183.7×+0.3
2017Dec 29, 20173.4×+0.3
2016Dec 30, 20163.2×−1.6
2015Dec 31, 20154.8×+0.3
2014Dec 31, 20144.5×−0.5
2013Dec 31, 20135.0×−2.3
2012Jul 31, 20127.3×–

More Integrated BioPharma figures

See a number that looks wrong?